Amazon Eyes Entering Japan Prescription Drug Market
Reuters2022-09-05
TOKYO, Sept 5 (Reuters) - Amazon.com Inc is considering entering the prescription drug sales market in Japan, the Nikkei newspaper reported on Monday.
Amazon plans to partner with small- and mid-sized pharmacies for the service, starting next year when electronic prescriptions are allowed for the first time in Japan, Nikkei said, citing people involved in the project.
Prescription drug prices in Japan are set by the government, while the distribution system is highly fragmented, with 70 wholesalers nationwide and almost 60,000 pharmacies.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
